Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial
Crossref DOI link: https://doi.org/10.1111/ijcp.12119
Published Online: 2013-01-25
Published Print: 2013-04
Update policy: https://doi.org/10.1002/crossmark_policy
Göke, Burkhard
Gallwitz, Baptist
Eriksson, Johan G.
Hellqvist, Åsa
Gause-Nilsson, Ingrid
Text and Data Mining valid from 2015-09-01
Publication History